CY1113416T1 - Μεθοδος παρασκευης δισκιων επικαλυμμενων με φιλμ που περιεχουν δροσπιρενονη ως δραστικο παραγοντα - Google Patents

Μεθοδος παρασκευης δισκιων επικαλυμμενων με φιλμ που περιεχουν δροσπιρενονη ως δραστικο παραγοντα

Info

Publication number
CY1113416T1
CY1113416T1 CY20121100930T CY121100930T CY1113416T1 CY 1113416 T1 CY1113416 T1 CY 1113416T1 CY 20121100930 T CY20121100930 T CY 20121100930T CY 121100930 T CY121100930 T CY 121100930T CY 1113416 T1 CY1113416 T1 CY 1113416T1
Authority
CY
Cyprus
Prior art keywords
drypirenone
active factor
manufacturing disc
disc covered
movies containing
Prior art date
Application number
CY20121100930T
Other languages
English (en)
Inventor
Attila Bódis
István Greiner
Kasza Jonathán Mihály Nagy
Original Assignee
Richter Gedeon Nyrt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt. filed Critical Richter Gedeon Nyrt.
Publication of CY1113416T1 publication Critical patent/CY1113416T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση αφορά επικαλυμμένο με φιλμ δισκίο που περιέχει δροσπιρενόνη με βελτιωμένη αντίσταση έναντι των περιβαλλοντικών επιδράσεων, ειδικά έναντι ατμοσφαιρικής υγρασίας. Η εφεύρεση περαιτέρω αφορά μέθοδο για την παρασκευή πυρήνων δισκίου επικαλυμμένου με φιλμ με την οποία η εφαρμογή του δραστικού παράγοντα στον πυρήνα μπορεί να επιτευχθεί με αυξημένη ασφάλεια.
CY20121100930T 2007-12-20 2012-10-05 Μεθοδος παρασκευης δισκιων επικαλυμμενων με φιλμ που περιεχουν δροσπιρενονη ως δραστικο παραγοντα CY1113416T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0700826A HUP0700826A3 (en) 2007-12-20 2007-12-20 Coated tablet containing drospirenone and process for producing the same
EP08462008A EP2072041B1 (en) 2007-12-20 2008-10-06 Method for preparing film-coated tablets containing drospirenone as active agent

Publications (1)

Publication Number Publication Date
CY1113416T1 true CY1113416T1 (el) 2016-06-22

Family

ID=89987951

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100930T CY1113416T1 (el) 2007-12-20 2012-10-05 Μεθοδος παρασκευης δισκιων επικαλυμμενων με φιλμ που περιεχουν δροσπιρενονη ως δραστικο παραγοντα

Country Status (23)

Country Link
US (1) US20110002993A1 (el)
EP (2) EP2072041B1 (el)
JP (1) JP5679819B2 (el)
CN (1) CN101896166B (el)
AU (1) AU2008339588B2 (el)
BR (1) BRPI0820450A2 (el)
CA (1) CA2708875A1 (el)
CY (1) CY1113416T1 (el)
DK (1) DK2072041T3 (el)
EA (1) EA017869B1 (el)
ES (1) ES2391953T3 (el)
HK (1) HK1147054A1 (el)
HR (1) HRP20120815T1 (el)
HU (1) HUP0700826A3 (el)
IL (1) IL205818A (el)
MY (1) MY148138A (el)
NZ (1) NZ585554A (el)
PL (1) PL2072041T3 (el)
PT (1) PT2072041E (el)
SI (1) SI2072041T1 (el)
UA (1) UA103182C2 (el)
WO (1) WO2009081216A1 (el)
ZA (1) ZA201003913B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160048305A1 (en) * 2014-08-14 2016-02-18 Microsoft Corporation Group-Based User Interface Rearrangement
RU2753049C2 (ru) * 2016-08-04 2021-08-11 БиПиЭсАй ХОЛДИНГЗ, ЭлЭлСи Легкие для глотания покрытия и покрытые ими субстраты
EP3747364A4 (en) * 2018-01-29 2021-11-10 PHC Holdings Corporation PROTECTIVE FILM MATERIAL FOR BIOCAPTER PROBE
WO2019176339A1 (ja) * 2018-03-13 2019-09-19 Ｐｈｃホールディングス株式会社 バイオセンサプローブ用保護膜材料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3022337A1 (de) 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
EP2044941A1 (en) * 1999-08-31 2009-04-08 Bayer Schering Pharma AG Multiple-phase formulation of drospirenone and estradiol as a contraceptive
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
JP2004315713A (ja) * 2003-04-18 2004-11-11 Shin Etsu Chem Co Ltd 非イオン性セルロースエーテルの製造方法及びこれにより得られる非イオン性セルロースエーテル造粒物
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
US8475838B2 (en) * 2005-06-03 2013-07-02 Sandoz Ag Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
EP1767194A1 (de) * 2005-06-09 2007-03-28 Helm AG Verfahren zur Herstellung von Adsorbaten des Drospirenons

Also Published As

Publication number Publication date
JP2011507825A (ja) 2011-03-10
CN101896166A (zh) 2010-11-24
PL2072041T3 (pl) 2012-12-31
NZ585554A (en) 2012-06-29
JP5679819B2 (ja) 2015-03-04
HUP0700826A3 (en) 2010-03-29
SI2072041T1 (sl) 2012-11-30
AU2008339588A1 (en) 2009-07-02
CA2708875A1 (en) 2009-07-02
UA103182C2 (ru) 2013-09-25
ZA201003913B (en) 2011-03-30
IL205818A0 (en) 2010-11-30
EP2446880A1 (en) 2012-05-02
IL205818A (en) 2016-05-31
DK2072041T3 (da) 2012-11-05
MY148138A (en) 2013-02-28
WO2009081216A1 (en) 2009-07-02
US20110002993A1 (en) 2011-01-06
HU0700826D0 (en) 2008-02-28
HK1147054A1 (en) 2011-07-29
EP2072041B1 (en) 2012-08-01
EP2072041A1 (en) 2009-06-24
ES2391953T3 (es) 2012-12-03
HRP20120815T1 (hr) 2012-11-30
PT2072041E (pt) 2012-10-31
CN101896166B (zh) 2013-05-01
EA017869B1 (ru) 2013-03-29
AU2008339588B2 (en) 2014-06-26
HUP0700826A2 (en) 2009-07-28
EA201001032A1 (ru) 2010-12-30
BRPI0820450A2 (pt) 2015-06-16

Similar Documents

Publication Publication Date Title
NZ709512A (en) Process for producing a coated packaging material and packaging material having at least one barrier layer for hydrophobic compounds
HK1220645A1 (zh) 含有甘油的改性絲膜
EA201391483A1 (ru) Фармацевтическая композиция
PL2537886T3 (pl) Warstwa powłokowa do folii przeciwodblaskowej i folia przeciwodblaskowa ją zawierająca
MX345777B (es) Formulaciones de tabletas bicapa.
PL2594614T3 (pl) Przeciwodblaskowa i przeciwoślepieniowa kompozycja powlekająca, folia przeciwodblaskowa i przeciwoślepieniowa oraz sposób ich wytwarzania
BR112012024139A2 (pt) formulações farmacêuticas de camada dupla contendo agonistas e antagonistas de opióide.
BRPI1014962A2 (pt) composição de revestimento, método, e, artigo revestido
EP2336253A4 (en) AQUEOUS COATING COMPOSITIONS, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING COATING FILM
EP2640989A4 (en) Adhesive film for bushings
BR112013008464A2 (pt) composição de revestimento.
UA111721C2 (uk) Безформальдегідне покриття для панелей, що містить співполімер полікислоти і порошок алюмосилікату кальцію
ECSP11010812A (es) Complejo de mineral-aminoácido polisacárido
PL2252722T3 (pl) Sposób wytwarzania zorientowanej według ziarna taśmy elektrycznej
EP3037489A4 (en) Anti-corrosion coating composition, anti-corrosion coating film, and method for protecting base material from corrosion
WO2012067349A3 (ko) 고분자 화합물 및 이를 포함하는 액침 노광 프로세스용 레지스트 보호막 조성물
CY1113416T1 (el) Μεθοδος παρασκευης δισκιων επικαλυμμενων με φιλμ που περιεχουν δροσπιρενονη ως δραστικο παραγοντα
PH12016500626A1 (en) Film coated tablet containing choline alfoscerate and process for preparing the same
EP2551308A4 (en) COATING COMPOSITION, PROCESS FOR PREPARING A FILM THEREFOR AND COATED BODY THEREWITH
EP2826885A4 (en) COPPER FILM-FORMING COMPOSITION AND METHOD FOR PRODUCING A COPPER FOIL USING THIS COMPOSITION
EP3006522A4 (en) Coating composition and coated film obtained therewith, multilayer structure and multilayer structure manufacturing method
MX337303B (es) Proceso para producir cuerpos moldeados revestidos.
UA115425C2 (uk) Фармацевтична композиція, що містить інозит
PH12016502537A1 (en) Composite preparation comprising active ingredient-containing film coating layer
BRPI0906813A2 (pt) Composição de revestimento metálico.